• Associate Professor Ben Wheeler (PI)
• Associate Professor Rhiannon Braund
• Associate Professor Barbara Galland
• Dr Matt Healey
• Dr Jinny Willis
• Associate Professor Craig Jefferies
• Dr Sarah Boucher
Identifying demographic characteristics of patients who discontinue insulin pump therapy
Insulin pump therapy is publicly funded in New Zealand via the special authority scheme set out by the New Zealand Pharmaceutical Management Agency (PHARMAC). Patients must meet certain criteria in order to obtain government funding for their insulin pump. They also have to reapply in nine months to renew this eligibility. If patients fail to meet certain treatment targets as specified by PHARMAC, they may have their insulin pump therapy funding taken away.
This project aims to identify groups who may be more likely to not succeed with insulin pump therapy, and expect that characteristics such as age, ethnicity, and deprivation will be associated. Identifying demographic characteristics of patients who discontinue insulin pump therapy will enable us to offer targeted education or more support to ensure patients success with this important but expensive therapy.